LEGN ▲ +0.9% - Legend Biotech Corporation $LEGN - Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting Legend Biotech rose 0.9% today following an announcement that the company will present updated long-term and real-world evidence data from its CARVYKTI clinical program at the International Myeloma Society Annual Meeting. The presentation of additional clinical data for the CAR-T cell therapy candidate may have reinforced investor confidence in the program's ongoing progress. 10-SEP-2026 08:01 AM ET